Dotamark M 80mg/250mg Tablet
Marketer
Indmark Biotech Private Limited
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Dotamark M 80mg/250mg Tablet
Abdominal pain is effectively managed by the combined medication, Dotamark M 80mg/250mg Tablet. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing chemical signals. Dosage and duration for Dotamark M 80mg/250mg Tablets should follow your physician's instructions, tailored to your individual response and condition. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Comprehensive disclosure of all other medications to your healthcare provider is vital, as interactions are possible. Common, usually transient side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately to your doctor. Dizziness and drowsiness are potential side effects; avoid driving or activities requiring alertness until effects are known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Prior to commencing treatment, inform your doctor of pregnancy, pregnancy plans, breastfeeding, or any existing kidney or liver conditions to ensure appropriate dosage.
Primary Ingredients of Dotamark M 80mg/250mg Tablet
No information provided. A rephrased version cannot be created.
Uses of Dotamark M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Dotamark M 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dotamark M 80mg/250mg Tablet with a meal.
Common Side effects of Dotamark M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Dotamark M 80mg/250mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dotamark M 80mg/250mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
How Dotamark M 80mg/250mg Tablet works:
Combiflam M, containing 80mg Drotaverine and 250mg Mefenamic Acid, provides relief from abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal muscle spasms by relaxing contractions. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), reduces pain and inflammation by inhibiting the production of specific inflammatory mediators.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dotamark M 80mg/250mg Tablet and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Dotamark M 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Dotamark M 80mg/250mg tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Dotamark M 80mg/250mg Tablets, a potential side effect of this medication, as it can induce vertigo.
KidneyCAUTION
Patients with kidney impairment should use Dotamark M 80mg/250mg Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dotamark M 80mg/250mg Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Dotamark M 80mg/250mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dotamark M 80mg/250mg Tablet :
Should you forget to take a Dotamark M 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dotamark M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently